Latest Commercial Partnerships News

Novatti has cashed in $1.2 million by selling part of its AUDC shares at $0.80 each, marking its first divestment since incubating the stablecoin issuer in 2022, yet keeps a substantial holding to benefit from future growth.

Echo IQ has locked in a binding Heads of Agreement with Pro Medicus for a strategic A$20 million investment and a US commercial partnership to accelerate adoption of its AI-powered cardiac diagnostic platform.

Tivan Limited has inked a Memorandum of Understanding with Aboriginal Investment NT to explore investment and Indigenous participation in the Molyhil Tungsten Project, advancing its critical minerals ambitions in the Northern Territory.

Pure Resources and Rice University have secured 'Awardable' status on the DARPA ERIS Marketplace for their advanced Carbon Nanotube Fibre 3D thermal management technology, positioning them for potential US Department of Defense contracts.

Dotz Nano has secured A$3.3 million through a private placement, backing its next phase of production scale-up and customer engagement under incoming CEO Nati Harpaz.

Cynata Therapeutics (ASX: CYP) has had its trading suspension lifted immediately following the publication of results from its Phase 3 Osteoarthritis and Phase 2 Graft versus Host Disease clinical trials.

Klevo Rewards’ Fly Wallet subsidiary is poised to launch a trial of its Australian dollar-backed stablecoin, KLVAUD, following legal advice confirming its eligibility under ASIC’s stablecoin framework.

Sparc Technologies secures its first international commercial partner as Petro Vietnam Paint commits to using ecosparc® in its PERAPHENE coatings range, targeting highly corrosive environments with improved anticorrosion performance.

Jade Gas Holdings has achieved a historic milestone with Mongolia’s first-ever approval of coal seam gas reserves, unlocking the path to commercial development of its TTCBM Project in the South Gobi.

EcoGraf confirms its patented HFfree process offers competitive costs for producing high-purity spherical graphite, targeting non-Chinese battery supply chains with plans for facilities in the US, Europe, and Asia.

Tetratherix Limited secures $15 million via institutional placement plus a capped $2 million share purchase plan at a 14% discount, aiming to fast-track manufacturing expansion and commercial partnerships.

Recce Pharmaceuticals has signed a non-binding term sheet with a major Middle Eastern pharma player for exclusive rights to commercialise its R327 Topical Gel across the MENA region, targeting a high diabetes burden market.